TY - JOUR
T1 - Peripartum management of pregnant women with congenital heart disease
AU - Yamasaki, Keiko
AU - Sawatari, Hiroyuki
AU - Konagai, Nao
AU - Kamiya, Chizuko A.
AU - Yoshimatsu, Jun
AU - Muneuchi, Jun
AU - Watanabe, Mamie
AU - Fukuda, Terunobu
AU - Mizuno, Atsushi
AU - Sakamoto, Ichiro
AU - Yamamura, Kenichiro
AU - Ohkusa, Tomoko
AU - Tsutsui, Hiroyuki
AU - Niwa, Koichiro
AU - Chishaki, Akiko
N1 - Funding Information:
H.T. received lecture fees from Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Bayer Pharmaceuticals Co., Ltd., and Pfizer Inc. H.T. received grants from Japan Tobacco Inc., Nippon Boehringer Ingelheim Co., Ltd., and Mitsubishi Tanabe Pharma Co., Ltd. H.T. received scholarship donations from MSD Co., Ltd., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Co., Ltd., Teijin Pharma Co., Ltd., and Nippon Boehringer Ingelheim Co., Ltd. All other authors have no conflicts of interest.
Funding Information:
This work was supported by a Grant-in-Aid for Scientific Research (B; #18H03083) and Grant-in-Aid for Young Scientists (Start-up; #15H06494) from the Ministry of Education, Culture, Sports, Science and Technology, and by an Intractable Disease Practical Application Business Grant (grant nos. 15ek0109123h0001, 16ek0109123h0002, and 17ek0109123h0003) from the Japan Agency for Medical Research and Development.
Funding Information:
We thank the staff members at the Kyushu University Hospital, Japan Community Healthcare Organization Kyushu Hospital, Department of Perinatology and Gynecology of the National Cerebral and Cardiovascular Center, and Cardiovascular Center of St. Luke’s International University Hospital for their help in collecting the data for the study. We also thank Kelly Zammit, BVSc, Susan Furness, PhD, and Jane Charbonneau, DVM, from Edanz Editing (www.edanzediting.com/ac), for editing drafts of this manuscript.
Publisher Copyright:
© 2019 Japanese Circulation Society. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Background: The average maternal age at delivery, and thus the associated maternal risk are increasing including in women with congenital heart disease (CHD). A comprehensive management approach is therefore required for pregnant women with CHD. The present study aimed to investigate the factors determining peripartum safety in women with CHD. Methods and Results: We retrospectively collected multicenter data for 217 pregnant women with CHD (age at delivery: 31.4±5.6 years; NYHA classifications I and II: 88.9% and 7.4%, respectively). CHD severity was classified according to the American College of Cardiology/American Heart Association guidelines as simple (n=116), moderate complexity (n=69), or great complexity (n=32). Cardiovascular (CV) events (heart failure: n=24, arrhythmia: n=9) occurred in 30 women during the peripartum period. Moderate or great complexity CHD was associated with more CV events during gestation than simple CHD. CV events occurred earlier in women with moderate or great complexity compared with simple CHD. Number of deliveries (multiparity), NYHA functional class, and severity of CHD were predictors of CV events. Conclusions: This study identified not only the severity of CHD according to the ACC/AHA and NYHA classifications, but also the number of deliveries, as important predictive factors of CV events in women with CHD. This information should be made available to women with CHD and medical personnel to promote safe deliveries.
AB - Background: The average maternal age at delivery, and thus the associated maternal risk are increasing including in women with congenital heart disease (CHD). A comprehensive management approach is therefore required for pregnant women with CHD. The present study aimed to investigate the factors determining peripartum safety in women with CHD. Methods and Results: We retrospectively collected multicenter data for 217 pregnant women with CHD (age at delivery: 31.4±5.6 years; NYHA classifications I and II: 88.9% and 7.4%, respectively). CHD severity was classified according to the American College of Cardiology/American Heart Association guidelines as simple (n=116), moderate complexity (n=69), or great complexity (n=32). Cardiovascular (CV) events (heart failure: n=24, arrhythmia: n=9) occurred in 30 women during the peripartum period. Moderate or great complexity CHD was associated with more CV events during gestation than simple CHD. CV events occurred earlier in women with moderate or great complexity compared with simple CHD. Number of deliveries (multiparity), NYHA functional class, and severity of CHD were predictors of CV events. Conclusions: This study identified not only the severity of CHD according to the ACC/AHA and NYHA classifications, but also the number of deliveries, as important predictive factors of CV events in women with CHD. This information should be made available to women with CHD and medical personnel to promote safe deliveries.
UR - http://www.scopus.com/inward/record.url?scp=85074184575&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074184575&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-19-0369
DO - 10.1253/circj.CJ-19-0369
M3 - Article
C2 - 31462608
AN - SCOPUS:85074184575
SN - 1346-9843
VL - 83
SP - 2257
EP - 2264
JO - Circulation Journal
JF - Circulation Journal
IS - 11
ER -